Abstract Porcine aortic endothelial cells (PAECs) in culture constitutivery secrete polypeptide (endothelium-derived) growth factors (EDGFs) into the surrounding medium. Incubation of PAECs with human peripheral blood polymorphonuclear leukocytes (PMNs) caused a significant increase in EDGF release as assessed by pH]thymidine incorporation into BALB/c 3T3 mouse fibroblasts and cell proliferation assay. The effect was time dependent and correlated with the number of PMNs, reaching a maximum with a 1:1 PAEC to PMN ratio. Generation of mitogenic activity was prevented by cycloheximide, indicating a requirement for de novo protein synthesis. Antibody-mediated inhibition assays suggested that mitogenic activity was due to platelet-derived growth factor and basic fibroblast growth factor. When supernatant from N-formyl-methionyl-leucyl-phenylalanine-stimulated PMNs was substituted for PMNs during incubation with PAECs, powerful mitogenic activity was generated, indicating the involvement of soluble mediators. A role for free oxygen radicals was ruled out by experiments in which superoxide dismutase and catalase did not prevent the increase in mitogenic activity. By contrast, serine protease inhibitors such as soybean trypsin inhibitor, a^antitrypsin, and eglin C reduced the PMN-stimulating activity by 70%, 80%, and 100%, respectively. The possible involvement of cathepsin G and elastase was investigated. Cathepsin G and elastase, when substituted for PMNs, increased the release of EDGFs in a dose-dependent fashion, mimicking the effect of PMNs. These findings suggest a new role for leukocyte-vessel wall interactions in the proliferative feature of atherosclerosis. (Arterioscler Thromb. 1994;14:125-132.)
S mooth muscle cell (SMC) proliferation accounts
for the intimal hyperplasia of the arterial wall, which is the main feature of fibrofatty atherosclerotic lesions. An accelerated form of this proliferative process appears to play a central role in the restenosis that occurs after angioplasty 1 and in premature artery disease in transplanted organs. 2 Release of growth-promoting factors by endothelial cells, macrophages, and activated platelets at the site of vascular injury leads to migration and proliferation of SMCs that may ultimately contribute to the intimal thickening observed in vascular stenosis. 3 The importance of mitogens released by endothelial cells during intimal formation has recently been emphasized in an aortic organ model system by Koo and Gotlieb. 4 These authors have shown that the mean number of SMCs present in the intima of the porcine aorta is correlated with the presence of a nondenuded endothelium or its conditioned medium.
Endothelial cells in vitro synthesize polypeptide growth factors, collectively named endothelium-derived growth factors (EDGFs), including basic fibroblast growth factor (bFGF) 5 - 7 and a platelet-derived growth factor (PDGF)-like molecule. 5 - 8 Enhanced secretion of EDGFs has been found after stimulation of cultured endothelial cells with agonists such as thrombin, 9 factor Xa, 10 low-molecular-weight fibrinogen degradation products, 11 bacterial endotoxin, 12 and tumor necrosis factor. 13 Received January 19, 1993 ; revision accepted October 17, 1993 . From the "Antonio Taticchi" Unit for Atherosclerosis and Thrombosis Research, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.
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Electron microscopy and immunohistochemical techniques have shown that in addition to SMCs, infiltrating cells such as monocytes/macrophages, T lymphocytes, and granulocytes are constituents of atherosclerotic lesions. 1416 Epidemiological studies have shown a direct correlation between the number of polymorphonuclear leukocytes (PMNs) and the incidence of ischemic disease. 17 ' 18 PMNs may contribute to vascular occlusion, damaging endothelial cells by secretion of several products, such as arachidonic acid metabolites, toxic oxygen species, and proteolytic enzymes such as cathepsin G and elastase. 19 PMNs may "switch" a healthy endothelium to a thrombogenic one by increasing endothelial cell plasminogen activator inhibitor activity. 20 Moreover, cathepsin G has been shown to stimulate plasminogen activator inhibitor release from human umbilical vein endothelial cells 21 and to increase albumin flux across the endothelial monolayer. 22 In addition, cathepsin G as well as elastase suppresses thrombin-induced prostacyclin production in human endothelial cells. 23 Among the various mechanisms by which PMNs might contribute to vascular occlusion, in the present study we investigated whether PMNs could modulate mitogen release by endothelial cells. The results indicate that PMNs enhance the release of EDGFs from endothelial cells. Specific antibody-mediated inhibition assays reveal that both PDGF and bFGF are produced and secreted after PMN challenge. Our data also suggest that the serine proteases cathepsin G and elastase may be responsible for the increased mitogenic activity. 0.02% EDTA were purchased from GIBCO BRL, Grand Island, NY. Fetal calf serum (FCS) was from Biochrom, Berlin, FRG. JV-2-hydroxyethylpiperazine-W-2-ethanesulfonic acid (HEPES) was obtained from Merck, Darmstadt, FRG. Dextran T-500 and Ficoll-Hypaque were from Pharmacia Fine Chemicals, Uppsala, Sweden. Cytochalasin B, Af-formyl-methionyl-leucyl-phenylalanine (fMLP), soybean trypsin inhibitor (SBTI; 1 mg protein inhibits 3 to 5 mg trypsin with an activity of approximately 10 000 BAEE U/mg protein), a,-antitrypsin (a,AT; 2 to 4 mg inhibit 1.0 mg trypsin with an activity of 10 000 BAEE U/mg protein), superoxide dismutase (SOD; activity, 2500 to 5000 U/mg protein), catalase (activity, 2000 to 5000 U/mg protein), serum bovine albumin (BSA), and cycloheximide were purchased from Sigma Chemical Co, St Louis, Mo. Eglin C, cathepsin G, and elastase from human neutrophils were from Calbiochem Biochemicals, San Diego, Calif). Goat anti-human PDGF and monoclonal anti-bovine bFGF antibodies were purchased from British Bio-technology Products Ltd, Oxdon, UK, and UBI, Lake Placid, NY, respectively. [Me</ry/- 
Cell Culture
Endothelial cells were obtained from porcine aortas as previously described. 24 For experiments, porcine aortic endothelial cells (PAECs) were plated in six-well plates at a concentration of 8x10*/well and grown to confluency in a humidified atmosphere of 93% air/7% CO 2 at 37°C in DMEM supplemented with 10% FCS, 100 U/mL penicillin, 100 Mg/mL streptomycin, and 1% glutamine. The number of PAECs at confluency was 5 x 10 5 /well.
PMNs and PMN-Derived Supernatant Preparations
Human blood was collected from healthy donors who had not taken any drugs during the 2 weeks preceding the study, with citrate as the anticoagulant. PMNs were isolated by dextran sedimentation and density-gradient centrifugation with Ficoll-Hypaque according to B0yum . 25 The cells were resuspended in 15 mmol/L HEPES/DMEM at the desired concentration. In some instances PMNs were stimulated by fMLP in the presence of cytochalasin B at 37°C. After 15 minutes the cells were sedimented by centrifugation (5 minutes at 12 000 rpm), and the supernatant was collected and extensively dialyzed against 15 mmol/L HEPES/DMEM to remove cytochalasin B before use in the release studies.
Release Studies
Confluent PAECs were washed with DMEM containing 2 mg/mL BSA followed by three washings with 15 mmol/L HEPES/DMEM at different intervals over a period of 24 hours. PAECs, PMNs, or PMN supernatants were incubated alone or together in 15 mmol/L HEPES/DMEM in a final volume of 1 mL at 37°C in 7% CO 2 over a period of 15 hours unless otherwise specified. When SBTI (100 Mg/mL), a, AT (1 mg/mL), eglin C (100 Mg/mL), SOD (50 Mg/mL) plus catalase (50 Mg/mL), or cycloheximide (1 Mg/mL) was used, it was added at the beginning of incubation. At the desired time the conditioned medium was collected, centrifuged for 5 minutes at 12 000 rpm to remove cellular debris, and stored at -20°C until the mitogenic assay. When cycloheximide was used the conditioned medium was extensively dyalized against 15 mmol/L HEPES/DMEM before the mitogenic assay.
Evaluation of Cell Damage
Cell number was estimated by hematocytometer counting, and viability was assessed by the trypan blue exclusion test. To assess cell damage, lactate dehydrogenase released into the endothelial cell-conditioned medium was measured with a colorimetric method (Sigma).
0-Glucuronidase Assay
To quantitate the release of azurophilic granules by PMNs, we measured the activity of ^-glucuronidase in the conditioned medium of PMNs incubated alone or in the presence of PAECs for various periods from 15 minutes to 15 hours. /J-Glucuronidase activity was measured according to Talalay et al. 26 This method is based on the generation of phenolphthalein from a phenolphthalein-/S-glucuronic acid complex by £-glucuronidase. The optical density of free phenolphthalein is measured at 540 nm and is proportional to the enzyme activity. Total 0-glucuronidase activity of 1O 6 PMNs was determined by lysing the cells with Triton X-100. Ten percent of the total enzyme activity generated by this number of PMNs was the detection limit of the assay. When the same number of PMNs was stimulated by fMLP (10"* mol/L) in the presence of cytochalasin B (2.5 Mg/mL), 40% of the total /3-glucuronidase was detected in the supernatant. In contrast no release could be detected from unstimulated PMNs. 0-GIucuronidase activity was also undetectable in the conditioned medium of PAECs coincubated with PMNs for 15 hours.
Mitogenic Activity Assays
The mitogenic activity of the endothelial cell-conditioned medium was evaluated by using BALB/c 3T3 mouse cell fibroblasts (clone A31, American Type Culture Collection) as described. 24 The 3T3 cells were plated at a concentration of 10 4 /well in 96-well microtiter plates, grown to near confluency, and induced to quiescence by a 48-hour exposure to DMEM supplemented with 5% human platelet poor plasma-derived serum prepared as described. 27 Aliquots of the endothelial cell-conditioned medium (5, 10, 20, 40, or 80 ML) were added to the 3T3 cell cultures and incubated in 7.5% CO 2 for 15 hours. [ 3 H]TdR was added, and after incubation for 3 hours the cells were washed and fixed to the well bottom with 10% cold trichloroacetic acid. The trichloroacetic acid-precipitable material was dissolved in 0.5 mol/L NaOH, collected, and counted in a beta counter. For each experiment a standard curve was generated by incubating 3T3 cells with increasing concentrations of CS. One unit of mitogenic activity was arbitrarily assigned as half the maximum activity obtained by CS.
In selected experiments the mitogenic activity was assessed by a cell proliferation assay. BALB/c 3T3 cells were seeded at 2x10*/well in 12-well plates in DMEM supplemented with 10% CS. After 24 hours the cells were washed and induced to quiescence by a 48-hour exposure to DMEM supplemented with 5% human platelet poor plasma-derived serum. Aliquots of conditioned medium from PAECs and/or PMNs were added to the wells and incubated for 24,48, or 72 hours. At the end of the incubation the cells were detached by exposure to trypsin/EDTA, and their number was estimated by hematocytometer counting.
Immunoinhibition Studies
The postculture medium from PAEC/PMN coincubation was preincubated with goat anti-human PDGF or monoclonal anti-bovine bFGF neutralizing antibodies for 1 hour at 37°C before the mitogenic assay. The antibodies were used at concentrations sufficient to inhibit 10 ng/mL PDGF and 20 ng/mL bFGF, respectively. These antibodies have been shown to neutralize the mitogenic activity of porcine PDGF and bFGF, respectively. Additional samples of postculture medium were preincubated with nonimmune goat immunoglobulin G or nonimmune mouse immunoglobulin G as described in the figure legends.
All of the reagents used in this study were dissolved in sterile solvents and filtered through nonpyrogenic, sterile 0.22-Mm Millex filters (Millipore, Molsheim, France). To avoid endotoxin contamination, sterile, pyrogen-free working conditions PMNs alone or together were incubated for different time intervals. A, Conditioned medium was collected at the indicated times, sedimented by centrtfugation, and tested for trrtiated thymidlne incorporation into BALB/c 3T3 as described. B, Conditioned medium was collected after 15 hours, sedimented by centrifugation, and tested in a cell proliferation assay on BALB/c 3T3 cells. The cells were detached after 24, 48, or 72 hours and counted as described.
were observed. All results represent the average of at least three separate experiments unless otherwise indicated.
Results

Effects of PMNs on Mitogen Release From PAECs
Cultured PAECs release growth factors into the medium in a time-dependent fashion that can be detected after a 15-hour incubation (Fig 1) . By contrast no mitogenic activity is measurable when the PMN-conditioned medium is tested. When PAECs were incubated with PMNs in a 1:2 ratio, powerful mitogenic activity was generated as assessed by pHJTdR incorporation into 3T3 cells. This activity became detectable between 1 and 3 hours and increased steadily with time, reaching an eightfold increase after 15 hours' incubation ( Fig 1A) . To determine whether mitogenesis was actually taking place, a cell proliferation assay was performed as described in "Methods." In a 72-hour incubation, cell counts rose to 19±2xl0 4 (mean±SE, n=3) or 47±10xl0 4 (n=3) when conditioned medium from PAECs or PAECs with PMNs was present, respectively ( Fig IB) . Conditioned medium from PMNs was ineffective.
We next examined the effect of incubation of PAECs with increasing numbers of PMNs. To determine whether PMNs were responsible for postsecretion modification of an inactive form of growth factor, endothelial cell-conditioned medium collected from PAECs incubated alone for 15 hours was further incubated with 10 6 PMNs/mL for an additional 15-hour period. Addition of PMNs to the endothelial cellconditioned medium did not modify the mitogenic activity expressed by the endothelial cell-conditioned medium (6.0±0.8 versus 5.8+1.0 U/mL, mean±SE, n=3), indicating that no postsecretion modification was taking place.
PMN-induced EDGF production was totally blocked by 1 /Ag/mL cycloheximide, indicating a requirement for de novo protein synthesis (Fig 3) . In pilot experiments this concentration of cycloheximide blocked protein synthesis by =95% and did not cause cell damage or loss.
Characterization of PDGF and bFGF-like Activity in Conditioned Media
To characterize the nature of the mitogenic activity, the specific neutralizing antibodies anti-PDGF and antibFGF were incubated with PAEC/PMN-conditioned medium before the mitogenic assay. As shown in Fig 4, goat anti-PDGF (10 /xg/mL) reduced the activity by 77% while a monoclonal anti-bFGF antibody (10 y.gl mT.) caused an inhibition of 52% (no further inhibition was obtainable after increasing the concentration of the antibodies), indicating that both mitogens were involved. When a mixture of the two antibodies was incubated with the postculture medium, the mitogenic activity was completely abolished. Nonimmune goat or mouse immunoglobulin G failed to significantly inhibit mitogenic activity.
Effect of PMNs on PAEC Morphology and Viability
The classic "cobblestone" morphology of resting, confluent PAECs is shown in Fig 5A. PMN with PAECs resulted in close apposition of PMNs on the endothelial cells. Repeated washings were sufficient to remove almost all of the PMNs. In some experiments no visible damage of the monolayer could be observed. In others, PAECs underwent a shape change characterized by cell retraction and formation of intercellular spaces between cells that had been adherent. The severity of the damage varied among experiments. Intercellular spaces were sometimes barely visible ( Fig  5B) ; alternatively, large areas of the bottom of the well were exposed, as shown in Fig 5C . Cell detachment could not be detected in any experiment as determined by cell count. PAEC viability by trypan blue exclusion after a 15-hour incubation in either the absence or presence of PMNs was 97±1% and 96±2% (mean±SE, n=5), respectively. Sublytic damage, as assessed by measuring the release of the cytoplasmic enzyme lactate dehydrogenase, gave comparable values for PAECs incubated alone or with PMNs for 15 hours. The finding that no cell detachment or sublytic damage could be observed indicates that exposure of the subendothelial matrix could be accounted for solely by cell retraction.
Effect of PMN Supernatants on EDGF Release
We next investigated whether the generation of mitogenic activity was attributable to soluble mediators or direct cell-cell contact. PMNs were incubated alone or with fMLP in the presence of cytochalasin B. After 15 minutes, the supernatants were cleared by centrifugation, diah/zed, and incubated with PAECs for 15 hours. The supernatant from unstimulated PMNs failed to significantly increase the mitogenic activity expressed by 300 FIG 6. Bar graph showing effect of potymorphonuclear leukocyte (PMN) supernatants on endothellum-derived growth factor release. Porcine aortic endothelial cells were incubated alone (control), with PMNs, or with PMNs or fMLP-stJmulated PMN supernatants (sn) prepared as described. The conditioned medium was collected after 15 hours and tested for mitogenlc activity. The activity Is expressed as mean±SE of three experiments. fMLP indicates N-formyl-methionyl-leucyl phenylalanine.
PAECs (Fig 6) . By contrast the supernatant from fMLPstimulated PMNs induced powerful activity that was even greater than that generated by the intact system in which PAECs and PMNs were incubated together. These results indicate that soluble mediators are responsible for the induced generation of EDGFs.
Effect of Oxygen-Radical Scavengers and Antiproteases on PMN-Induced EDGF Release
PMN h/sosomal granules contain several proteinases that can be released on PMN activation. Moreover, PMNs generate toxic oxygen species that can modulate several biological functions of the endothelium and affect its integrity. 28 The possible role of PMN-derived products, such as neutral lysosomal proteases and toxic oxygen radicals, was then investigated. The serine protease inhibitors SBTI (100 Mg/mL), dAT (1 mg/mL), and eglin C (100 jtg/mL) and the oxygen-radical scavengers SOD (50 /xg/mL) and catalase (50 fig/mL) were incubated with PAECs and PMNs. SBTI, a,AT, and eglin C but not SOD or catalase prevented the PMNinduced morphological change when this occurred. For mitogenic activity, the effect of these reagents are shown in Fig 7. The mitogenic activity expressed in the conditioned medium from PAECs incubated with PMNs in the absence of inhibitors was assigned a value of 100%. SOD and catalase did not affect the increase of EDGF release by PMN-stimulated PAECs. By contrast, SBTI and a,AT decreased EDGF release by 70% and 80%, respectively. Moreover, addition of eglin C, a specific inhibitor of elastase and cathepsin G, 29 completely prevented the increase of EDGF release induced by PMNs. In addition, in those cultures in which PMNs induced a change in PAEC shape, eglin C prevented this morphological modification. Addition of the inhibitors themselves to the PMN/PAEC-conditioned medium did not affect its mitogenic property, indicating that these inhibitors do not neutralize the mitogenic activity once released (not shown). These results seem to indicate that serine proteases, such as elastase and/or cathepsin G, contribute to an increase in EDGF release.
Effect of Purified Cathepsin G and Elastase on EDGF Release
To further test this hypothesis, purified elastase or cathepsin G was added to confluent PAECs instead of PMNs. In the presence of each separate enzyme, mitogenic activity was enhanced in a dose-dependent manner (Fig 8) . The effect was already observed with as little as 10 nmol/L of either enzyme. At higher concentrations (100 nmol/L for elastase and 25 nmol/L for cathepsin G), a plateau was reached. Moreover, at each concentration the enhancing effect of elastase was To rule out the possibility that the increase in mitogenic activity was due to endotoxin contamination, cathepsin G and elastase were boiled for 15 minutes before incubation with PAECs. No increase in mitogenic activity was detected in this condition, indicating that the enhancing effect was solely attributable to cathepsin G and elastase (Fig 8) .
PAEC morphology was also examined. PAECs incubated with cathepsin G were not different from control cells. By contrast, elastase caused cell retraction that was detectable at 20 nmol/L and increased with higher concentrations (not shown). However, even at high concentrations (200 nmol/L), cell number and viability were indistinguishable from those of control PAECs.
To exclude the possibility that modulation of EDGF release might result from species incompatibility, selected experiments were carried out to test human PMNs on human umbilical vein endothelial cells. Human PMNs consistently stimulated EDGF release from both PAECs and human umbilical vein endothelial cells. A complete report of these experiments will be published elsewhere.
Discussion
In this article we report that human PMNs enhance the release of EDGFs from PAECs. The effect can already be observed after a 1-to 3-hour incubation and increases with time. The amount of EDGFs released also correlates with the number of PMNs and reaches a maximum at a PMN to PAEC ratio of 1:1. Although to a different degree, the same results were obtained when human umbilical vein endothelial cells were substituted for PAECs, ruling out the possibility that species incompatibility could be responsible for the increase in growth factor release.
As opposed to the supernatant of unstimulated PMNs, the supernatant from fMLP-stimulated PMNs per se was able to induce generation of mitogenic activity. The activity generated by this supernatant was greater than that detected when the same number of PMNs was incubated with PAECs.
These findings clearly assign a role for soluble mediators and suggest that exposure of PMNs to endothelial cells may be sufficient to induce at least a partial PMN lysosomal granule release. Measurement of the specific azurophilic granule marker /3-glucuronidase in the supernatant of PMNs, incubated with or without PAECs, gave negative results. However, partial granule release below the detection limit of the assay cannot be excluded. It should also be considered that PMN interaction with PAECs may create a stimulatory environment for PMNs. In fact, endothelial cells produce substances such as platelet activating factor 30 or PDGF-like molecules, which have been shown to promote PMN activation. 31 - 32 Moreover, the involvement of adhesion proteins responsible for PMN interaction with endothelial cells cannot be excluded.
The proposed role for soluble mediators had led us to study the nature of the molecule(s) released from PMNs. A role for toxic oxygen species has been ruled out in our experimental system. By contrast, the serine protease inhibitors SBTI, a,AT, and eglin C reversed the PMN-stimulating effect to various degrees. The most effective was eglin C, a low-molecular-weight inhibitor of cathepsin G and elastase. Cathepsin G and elastase are present in large amounts in PMN azurophilic granules 33 and have been shown to modulate several endothelial functions. 2123 Cathepsin G and elastase, incubated with PAECs but in the absence of PMNs, increased the release of EDGFs in a dosedependent fashion, mimicking the effect of PMNs. Elastase at a concentration of 10 nmol/L, induced an increase in mitogenic activity that was comparable to that obtained when 10 6 PMNs were incubated with PAECs. According to previous observations, 34 this elastase concentration accounts for 20% of the total content of the enzyme in 10 6 PMNs. Altogether, these results indicate that either cathepsin G, elastase, or both could be responsible for the increase in EDGF release.
It could be argued that under more physiological conditions, PMNs and the endothelium only interact in plasma, which is rich in scavengers and antiproteases that would inhibit cathepsin G and elastase that are possibly released by PMNs. However, it should be mentioned that close contact between PMNs and other cell types would create a protected microenvironment in which cathepsin G and elastase could not be reached by the enzyme inhibitors present in plasma. 35 -36 The morphology of PAEC monolayers after challenge with PMNs was different among the experiments and was related to considerable donor-to-donor variability. In some experiments PAECs retained their normal cobblestone morphology; in others the cells underwent a change in shape, with consistent enlargement of intercellular spaces. However, in both cases, cell number, viability, and lactate dehydrogenase release were similar to those of PAECs incubated alone. Although injury to cultured endothelial cells causes release of growth factors into the surrounding medium, 37 it has also been shown that mitogenic activity of lysates from endothelial cells accounts for only a small amount of the activity found in endothelial cell-conditioned medium.
11
- 27 Endothelial cells synthesize PDGF, which has been shown to be secreted into the surrounding medium, 5 -8 ' 24 and bFGF, which has been reported to remain cell associated 5 or deposited in the extracellular matrix. 38 In the present study the enhancement in EDGF release was measured both when cells retracted and when cells retained the normal cobblestone morphology. Moreover, although elastase affected the morphology of the monolayer, cathepsin G at the concentrations used caused an increase in mitogenic activity that was not accompanied by visible cell retraction. Addition of PMNs to the postculture endothelial cellconditioned medium failed to generate mitogenic activity, ruling out the possibility of the involvement of an inactive form of growth factors. In addition, the activity was completely suppressed by cycloheximide. These findings support the hypothesis that the mitogenic activity detected in the endothelial cell-conditioned medium of PAECs exposed to PMNs results in de novo protein synthesis and that the EDGFs are not derived from an internal storage pool or from the extracellular matrix, as has been reported by Ishai-Michaeli et al.
Modulation of EDGF synthesis and secretion has been previously reported. Several agents increase the PDGF-like mitogen from endotheliaJ cells, 7   - 11 whereas enhanced release of bFGF or a bFGF-like molecule has been documented from irradiated cells 27 or PAECs that have been exposed to low-molecular-weight fibrinogen degradation products. 11 Our data show that PMNs induce production and secretion of at least two peptide growth factors, which are either very similar or identical to PDGF and bFGF. This finding is supported by data obtained by antibody-mediated inhibition of the mitogenic activity. Although this activity is completely suppressed when postculture medium is incubated with a mixture of the anti-PDGF and anti-bFGF antibodies, the possibility that other substances such as interleukin-1, insulin growth factors, or transforming growth factors may have contributed to the activity cannot be completely dismissed. Several studies support the hypothesis that mitogens are involved in intimal thickening, a feature characteristic of atherosclerotic plaques. Extracts from human atherosclerotic lesions contain high levels of transcription of the sis gene (which encodes for the B chain of PDGF 40 ) , and endothelial cells have been reported to be one of the predominant cell types that express PDGF chain mRNA in atherosclerotic plaques. 41 Epidemiological studies have linked PMN counts to the risk of ischemic vascular disease. 17 - 42 A positive correlation between leukocyte count and the severity of coronary artery disease as evaluated by coronary angiography has been described. 43 Evidence for leukocytosis in diet-induced atherosclerosis in rabbits and humans with familial hypercholesterolemia has also been reported. 44 - 45 Moreover, the presence of neutrophils in dietinduced aortic fatty streaks in green monkeys has been documented by Trillo. 16 SMC hyperplasia is considered to be an important feature of the atherosclerotic lesion. In experimental models of neointimal formation that were induced by perivascular manipulation to avoid direct injury of endothelial cells, adherence of PMNs to the endothelium and subsequent invasion into the intimal and medial layers of the vessel wall was observed as an early event preceding intimal SMC proliferation. 4 *" 48 PMN adhesion to the endothelium represents an early event in the acute inflammatory response and pathogenesis of vascular disease. Cellular components of the atherosclerotic lesion synthesize cytokines, which are known to induce adhesion molecules for leukocytes. 49 In addition, immunohistochemical studies have shown the presence of the intercellular adhesion molecule-1 on endothelial cells of human atherosclerotic plaques. 50 Taken together, these observations suggest that a PMN/ endothelial cell interaction may occur during the development of atherosclerosis. Although few studies report the presence of neutrophils in atherosclerotic lesions, it cannot be excluded that under certain circumstances, a dynamic, short-lived interaction may occur between neutrophils and endothelium-generating conditions in which endothelial functions could be drastically modified.
In the present study we have shown that PMNs enhance the secretion of growth factors that are immunologically related to PDGF and bFGF from endothelial cells. This effect seems to be related to proteases such as elastase and cathepsin G, which may be released on incubation of PMNs with PAECs. The results, described for the first time in this article, suggest a new role for PMNs in the progression of vascular occlusion, since they offer evidence for a possible pathway of a PMN-induced switch of the endothelium toward an "atherogenic phenotype."
